港股異動 | 富力地產(2777.HK)大幅高開12.12% 獲主要股東提供80億港元股東資金
格隆匯9月21日丨富力地產(2777.HK)大幅高開12.12%,報4.81港元,最新市值180億港元。富力地產昨日晚間發公吿稱,李思廉博士及張力先生(統稱主要股東)各為公司的執行董事及大股東,已與集團溝通,彼等為支持集團將提供約港幣80億元的股東資金,並預計於未來一至兩個月內完成。公司預期於2021年9月21日收到約港幣24億元。主要股東以往曾以免息貸款形式提供財務支持,展現主要股東對集團的持續承諾及彼等對集團業務及發展堅定不移的信心。此外據悉,富力集團旗下的富力物業公司昨日也與碧桂園簽署股權轉讓協議,碧桂園將以不超過100億元收購富良環球。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.